Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia.

Suppr

超能文献

作者信息

Quignon F, Chen Z, de Thé H

机构信息

CNRS UPR 9051, Hopital St Louis 1, Paris, France.

出版信息

Biochim Biophys Acta. 1997 Dec 9;1333(3):M53-61. doi: 10.1016/s0304-419x(97)00025-5.

DOI:10.1016/s0304-419x(97)00025-5

PMID:9426202

Abstract

摘要

相似文献

Retinoic acid and arsenic: towards oncogene-targeted treatments of acute promyelocytic leukaemia.

Biochim Biophys Acta. 1997 Dec 9;1333(3):M53-61. doi: 10.1016/s0304-419x(97)00025-5.

Pathogenetic role of the PML1RAR alpha fusion protein in acute promyelocytic leukemia.

Curr Top Microbiol Immunol. 1996;211:269-78. doi: 10.1007/978-3-642-85232-9_27.

[Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?].

C R Seances Soc Biol Fil. 1998;192(2):273-81.

Retinoic acid induces the degradation of the leukemogenic protein encoded by the promyelocytic leukemia gene fused to the retinoic acid receptor alpha gene.

Nutr Rev. 2000 Jul;58(7):211-4. doi: 10.1111/j.1753-4887.2000.tb01865.x.

Acute promyelocytic leukemia: from genetics to treatment.

Blood. 1994 Jan 1;83(1):10-25.

[Role of retinoic acid in the treatment of acute promyelocytic leukemia].

Sangre (Barc). 1993 Oct;38(5):375-8.

Acute promyelocytic leukaemia and the t(15;17) translocation.

Semin Cancer Biol. 1993 Dec;4(6):359-67.

The t(15;17) translocation in acute promyelocytic leukemia.

Leukemia. 1994 Oct;8(10):1615-21.

Retinoic acid receptor alpha in acute promyelocytic leukaemia.

Cancer Surv. 1992;14:195-203.

Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.

Genes Chromosomes Cancer. 1996 Mar;15(3):147-56. doi: 10.1002/(SICI)1098-2264(199603)15:3<147::AID-GCC1>3.0.CO;2-2.

引用本文的文献

Differentiation therapy revisited.

Nat Rev Cancer. 2018 Feb;18(2):117-127. doi: 10.1038/nrc.2017.103. Epub 2017 Dec 1.

Preclinical mouse cancer models: a maze of opportunities and challenges.

Cell. 2015 Sep 24;163(1):39-53. doi: 10.1016/j.cell.2015.08.068.

Uncoupling RARA transcriptional activation and degradation clarifies the bases for APL response to therapies.

J Exp Med. 2013 Apr 8;210(4):647-53. doi: 10.1084/jem.20122337. Epub 2013 Mar 18.

Gene mutations and molecularly targeted therapies in acute myeloid leukemia.

Am J Blood Res. 2013;3(1):29-51. Epub 2013 Jan 17.

The cell biology of disease: Acute promyelocytic leukemia, arsenic, and PML bodies.

J Cell Biol. 2012 Jul 9;198(1):11-21. doi: 10.1083/jcb.201112044.

Acute promyelocytic leukaemia: novel insights into the mechanisms of cure.

Nat Rev Cancer. 2010 Nov;10(11):775-83. doi: 10.1038/nrc2943. Epub 2010 Oct 22.

Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting.

Int J Hematol. 2010 Jun;91(5):742-7. doi: 10.1007/s12185-010-0582-0. Epub 2010 May 11.

PML nuclear bodies.

Cold Spring Harb Perspect Biol. 2010 May;2(5):a000661. doi: 10.1101/cshperspect.a000661. Epub 2010 Apr 21.

DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia.

Cell Growth Differ. 2001 Feb;12(2):85-98.

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14807-12. doi: 10.1073/pnas.96.26.14807.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验